Low-Level Light Therapy for Post-Training Recovery - Quick Reference Sheet

Low-Level Light Therapy for Post-Training Recovery

Created on 07/03/2026 – Quick Reference based on Evidence Review created using AI4L / Opus 4.8 Audit

Low-power red and near-infrared light applied to the skin before a workout can reduce muscle fatigue, allow a few more repetitions, and lower blood markers of muscle strain, with a more moderate signal for less next-day soreness. Maximal-strength recovery is inconsistent and whole-body light beds have not worked. Very safe with careful dosing; evidence remains uneven and often low-certainty. (Full Review)

Protocol

Timing
Pre-exercise
Localized over target muscles, ~30 min before to immediately before exercise
Wavelength
Red + near-infrared
630–660 nm red and 800–850 nm near-infrared combined
Dose
20–60 J per site
50–200 mW per point; respect the biphasic dose ceiling
Time to effect
Fatigue & endurance
Same session
More repetitions when applied pre-exercise
Soreness & damage markers
24–72 hours
Lower soreness and muscle-strain markers
Training adaptations
Weeks
Requires weeks of consistent use

Benefits

Contraindications
  • Direct application over known or suspected malignancy
  • Over the gravid uterus during pregnancy
  • Over the thyroid (anterior neck) without guidance
  • Photosensitivity disorders (porphyria, active lupus)
  • Active hemorrhage
  • Melanoma or pigmented lesion under evaluation
  • Inability to use eye protection
  • Pulsed/flickering devices with photosensitive epilepsy
  • Class 3B/4 lasers without certified eyewear
Key Interactions
  • Photosensitizing drugs (tetracyclines, fluoroquinolones, retinoids, amiodarone, thiazides)
  • Topical retinoids and St. John's Wort
  • High-dose antioxidants (vitamin C, E, N-acetylcysteine)
  • Corticosteroid injections and topical steroids
  • Immediate post-session ice

Risk & Side Effects

  • High: Eye and retinal injury from direct exposure
  • Medium: Skin warmth, erythema, and thermal burns; loss of benefit from overdosing
  • Low: Photosensitivity reactions; headache or eye strain
  • Speculative: Blunting of long-term exercise adaptations; stimulation of pre-existing malignancy

Monitoring

Marker Target Why
Creatine kinase (CK) ~40–200 U/L at rest Tracks exercise-induced muscle damage and whether light lowers it
Lactate dehydrogenase (LDH) ~120–250 U/L Secondary marker of muscle-cell stress and turnover
C-reactive protein (CRP), high-sensitivity < 1.0 mg/L Gauges systemic inflammation and recovery load
Blood lactate (post-exercise) < 2 mmol/L with recovery Reflects metabolic clearance after intense effort

Cadence: Baseline before starting; track across the first 2–4 weeks of consistent use, then every 4–8 weeks or when training blocks change

Qualitative Assessment

  • Perceived muscle soreness (0–10 scale) at 24 and 48 hours after hard sessions
  • Perceived recovery and readiness to train the next day
  • Sleep quality and duration
  • Session performance (repetitions, jump height, or pace) on matched workouts
  • Energy levels and motivation across a training block